Crossmark

Prophylactic potential of honey and Nigella sativa L. against hospital and community-based SARS-CoV-2 spread: a structured summary of a study protocol for a randomised controlled trial

Crossref DOI link: https://doi.org/10.1186/s13063-021-05510-3

Published Online: 2021-09-15

Published Print: 2021-12

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Ashraf, Sohaib http://orcid.org/0000-0003-3127-3557
Ashraf, Shoaib http://orcid.org/0000-0002-1218-4877
Akmal, Rutaba

Ashraf, Moneeb http://orcid.org/0000-0002-5769-9524
Kalsoom, Larab

Maqsood, Aadil

Imran, Muhammad Ahmad http://orcid.org/0000-0003-3358-229X
Farooq, Iqra http://orcid.org/0000-0002-9832-9589
Ashraf, Sidra http://orcid.org/0000-0002-4254-2583
Siddiqui, Uzma Nasim

Ghufran, Muhammad

Akram, Muhammad Kiwan

Majeed, Nighat

Rafique, Sundas

Habib, Zaigham

Shahab, Muhammad Sarmad

Akmal, Adeen

Shaukat, Zeeshan

Abdin, Zain ul

Khaqan, Ayesha

Arshad, Shahroze

Rehman Virk, Muhammad Abdul

Gul, Mehak

Awais, Abeer bin

Hassan, Muhammad

Khalid, Noman

Iqbal, Qurrat Ul Ain

Ahmad, Tausif

Akram, Muaaz

Muhammad, Ameer

Khalil, Musa

Aslam, Aneeq

Umer, Muhammad

Sherazi, Syed Sami Hussain http://orcid.org/0000-0002-8703-6342
Safdar, Zartasha http://orcid.org/0000-0002-0837-8812
Ahmad, Sohail

Bilal, Muhammad

Zahid, Muhammad Nauman

Koshak, Abdulrahman E.

Hilal, Abubakar

Malik, Ahmad Azam

Iqbal, Usman

Baig, Atif Amin

Alahmadi, Yaser Masuod

Humayun, Ayesha

Malik, Amber

Ahmad, Ali

Ashraf, Muhammad

Saboor, Qazi Abdul

Izhar, Mateen

,

Muhammad, Arz

Hayat, Kanwal

Amjad, Ghazala

Kousar, Misbah

Hafeez, Umair

Mughal, Tayyab

Muzafar, Tayyaba

Zulfiqar, Sibgha

Alam, Saadia Shahzad

Anwar, Muhammad Imran

Malik, Amber

Mahmud, Talha

Arshad, Ali

Nawaz, Khawar

Yousaf, Muhammad Ismail Khalid
Funding

Funding for this research was provided by:

smile welfare organization
License Information

Text and Data Mining valid from 2021-09-15

Version of Record valid from 2021-09-15
More Information

Article History

Received: 29 July 2021

Accepted: 4 August 2021

First Online: 15 September 2021

Declarations

:

: The trial was approved by institutional ethical review board of Shaikh Zayed Post-Graduate Medical Complex (IRB ID # SZMC/IRB/Internal/273/2021) on February 15, 2021. Authors certify that the study has received ethical approval from the appropriate ethical committee as stated above. Before enrolment, all partakers will be fully informed of the study and asked to sign the consent form to be eligible for randomization and participation.

: Not applicable

: The authors declare that they have no competing interests.

Document is current

Any future updates will be listed below